Maze Therapeutics MAZE
NASDAQ MAZE
$32.58 +0.13 (+0.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Ending Cash Balance (2024 - 2026)

Updated

Analysis

Maze Therapeutics (MAZE) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.42 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.57 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.03 Bn
10 Maze Therapeutics 1.92 Bn 434.24 Mn - 203.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 203.73 Mn
Mar 31, 2026 199.85 Mn
Dec 31, 2025 190.34 Mn
Sep 30, 2025 317.86 Mn
Jun 30, 2025 265.63 Mn
Mar 31, 2025 295.46 Mn
Dec 31, 2024 197.90 Mn
Sep 30, 2024 150.70 Mn
Jun 30, 2024 176.15 Mn
Mar 31, 2024 31.11 Mn
API Access

Maze Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=MAZE&period=max&api_key=YOUR_API_KEY